Evidence map›Paper›PMID 33767307›Full record

ArticleScientific reports2021

Population genomic analyses of schistosome parasites highlight critical challenges facing endgame elimination efforts.

Jonathan A Shortt, Laura E Timm, Nicole R Hales, Zachary L Nikolakis, Drew R Schield, Blair W Perry, Yang Liu, Bo Zhong, Todd A Castoe, Elizabeth J Carlton and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Jonathan A Shortt *Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Laura E Timm *Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Nicole R HalesDepartment of Biology, University of Texas at Arlington, Arlington, TX, 76109, USA.
Zachary L NikolakisDepartment of Biology, University of Texas at Arlington, Arlington, TX, 76109, USA.
Drew R SchieldDepartment of Biology, University of Texas at Arlington, Arlington, TX, 76109, USA.
Blair W PerryDepartment of Biology, University of Texas at Arlington, Arlington, TX, 76109, USA.
Yang LiuInstitute of Parasitic Disease, Sichuan Center for Disease Control and Prevention, Chengdu, People's Republic of China.
Bo ZhongInstitute of Parasitic Disease, Sichuan Center for Disease Control and Prevention, Chengdu, People's Republic of China.
Todd A Castoe *Department of Biology, University of Texas at Arlington, Arlington, TX, 76109, USA.
Elizabeth J Carlton *Department of Environmental and Occupational Health, University of Colorado Anschutz Medical Campus, Colorado School of Public Health, Aurora, CO, 80045, USA.
David D Pollock *Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA. David.Pollock@CUAnschutz.edu.
The University of Texas at Arlington · USUniversity of Colorado Anschutz Medical Campus · USSichuan Center for Disease Control and Prevention · CNColorado School of Public Health · US

Funding

Computational Bioscience Program Training GrantT15LM009451 · NLM · UNIVERSITY OF COLORADO DENVER · PI Katherina Kechris-Mays, Arjun Krishnan · 2007 to 2026
$11.7M
Schistosomiasis at the edge of elimination: characterizing sources of new infections in residual transmission hotspotsR01AI134673 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CARLTON, ELIZABETH · 2019 to 2023
$3.5M
Modeling evolution of functional context in proteinsR01GM083127 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI POLLOCK, DAVID D · 2009 to 2019
$2.7M
Determinants of Schistosomiasis Re-emergenceR01AI068854 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI SPEAR, ROBERT C · 2007 to 2011
$2.3M
Identifying parasite reservoirs in areas approaching eliminationR21AI115288 · NIAID · UNIVERSITY OF COLORADO DENVER · PI CARLTON, ELIZABETH · 2015 to 2016
$409k
NIAID NIH HHS R01 AI068854NIAID NIH HHS R01 AI134673NIAID NIH HHS R21 AI115288NIGMS NIH HHS R01 GM083127NLM NIH HHS T15 LM009451
6 · The paper itself

Abstract

Schistosomiasis persists in Asian regions despite aggressive elimination measures. To identify factors enabling continued parasite transmission, we performed reduced representation genome sequencing on Schistosoma japonicum miracidia collected across multiple years from transmission hotspots in Sichuan, China. We discovered strong geographic structure, suggesting that local, rather than imported, reservoirs are key sources of persistent infections in the region. At the village level, parasites collected after referral for praziquantel treatment are closely related to local pre-treatment populations. Schistosomes within villages are also highly related, suggesting that only a few parasites from a limited number of hosts drive re-infection. The close familial relationships among miracidia from different human hosts also implicate short transmission routes among humans. At the individual host level, genetic evidence indicates that multiple humans retained infections following referral for treatment. Our findings suggest that end-game schistosomiasis control measures should focus on completely extirpating local parasite reservoirs and confirming successful treatment of infected human hosts.

Indexed as

Genetic VariationMetagenomicsSelection, GeneticAnimalsChinaGenotypeHumansSchistosoma japonicumSchistosomiasis japonica

Identifiers

PMID33767307
PMCPMC7994584
OpenAlexW3138487950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.